The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 7
- 7 new
- Median first-year cost
- $3,390,271
- $20,478,376 in all
- Institutions
- 5
- 7 contact PIs
Awards by fiscal year
0
0
0
7
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- EMORY UNIVERSITY2
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- DUKE UNIVERSITY1
- SAGE BIONETWORKS1
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-6 (A2))7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2017 | Deconstructing and modeling the single cell architecture of the Alzheimer brain1RF1AG057473-01 | Bennett, David AlanDe Jager, Philip L | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $3,591,103 | Study section ZAG1 |
| FY2017 | Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease1RF1AG057440-01 | Haroutunian, VahramNoggle, Scott AllenRoussos, PanagiotisZhang, Bin | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $3,514,658 | Study section ZAG1 |
| FY2017 | Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease1RF1AG057452-01 | Kaddurah-Daouk, Rima FKastenmuller, GabiPrice, Nathan D | DUKE UNIVERSITY, NC | First-year cost $3,509,523 | Study section ZAG1 |
| FY2017 | Open systems for AMP-AD target enhancement1RF1AG057443-01 | Brennan , PaulMangravite, Lara MPrice, Nathan DSchadt, Eric E | SAGE BIONETWORKS, WA | First-year cost $3,390,271 | Study section ZAG1 |
| FY2017 | Brain - Plasma Proteomics Biomarker Discovery and Validation in the US and UK1RF1AG057471-01 | Bennett, David AlanLevey, Allan ILovestone, SimonSeyfried, Nicholas Thomas | EMORY UNIVERSITY, GA | First-year cost $3,174,907 | Study section ZAG1 |
| FY2017 | Building a high-resolution multi-omic AD interactome with the AMP-AD and M2OVE-AD Projects1RF1AG057470-01 | Hajjar, Ihab MSeyfried, Nicholas Thomas | EMORY UNIVERSITY, GA | First-year cost $3,079,393 | Study section ZAG1 |
| FY2017 | Building Novel Predictive Networks for high-throughput, in-silico Key Driver Prioritization to Enhance Drug Target Discovery in AMP-AD and M2OVE-AD1RF1AG057457-01 | Chang, RuiYoung-Pearse, Tracy L | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $218,521 | Study section ZAG1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.